From the Anagenics divestment of Advangen Japan (only)
• Important intellectual property (patents and certain trademarks) developed under the ownership of ADV Japan have been reassigned and continue to remain under the full ownership and control of AN1. The control of key patents and trademarks worldwide ensures AN1 retains full access to international markets, including China and Japan, for its évolis® brands and core FGF5 inhibitor technologies.
This does not say " but only in relation to hair loss"
AN1 Price at posting:
3.5¢ Sentiment: Buy Disclosure: Held
